Currently, it remains controversial whether ZC3H7A/B::BCOR-positive sarcomas constitute another provisional entity of a “fusion-driven” soft tissue sarcoma or a genetic subset/variant in the spectrum of malignant OFMTs or BCOR-rearranged sarcomas. The gene discussed is BCOR; the disease is soft tissue sarcoma.